CN107198766B - 一种用于养颜的中药组合物及其制备方法和应用 - Google Patents
一种用于养颜的中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN107198766B CN107198766B CN201710351767.2A CN201710351767A CN107198766B CN 107198766 B CN107198766 B CN 107198766B CN 201710351767 A CN201710351767 A CN 201710351767A CN 107198766 B CN107198766 B CN 107198766B
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- skin
- beautifying
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 102000008186 Collagen Human genes 0.000 claims abstract description 38
- 108010035532 Collagen Proteins 0.000 claims abstract description 38
- 229920001436 collagen Polymers 0.000 claims abstract description 38
- 239000000284 extract Substances 0.000 claims abstract description 29
- 235000019206 astragalus extract Nutrition 0.000 claims abstract description 18
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 14
- 239000002775 capsule Substances 0.000 claims description 24
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 14
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 14
- 229960002591 hydroxyproline Drugs 0.000 claims description 14
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 14
- 241000125175 Angelica Species 0.000 claims description 13
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims description 4
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims description 4
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 claims description 4
- 229940114124 ferulic acid Drugs 0.000 claims description 4
- 235000001785 ferulic acid Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims description 4
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 claims description 3
- 230000002708 enhancing effect Effects 0.000 claims description 3
- 235000013402 health food Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 21
- 230000036541 health Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 43
- 241000699670 Mus sp. Species 0.000 description 27
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 12
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 12
- 229940118019 malondialdehyde Drugs 0.000 description 12
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 102000019197 Superoxide Dismutase Human genes 0.000 description 9
- 108010012715 Superoxide dismutase Proteins 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 230000003796 beauty Effects 0.000 description 8
- 241000382455 Angelica sinensis Species 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000037303 wrinkles Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 210000000697 sensory organ Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- PSFDQSOCUJVVGF-UHFFFAOYSA-N harman Chemical compound C12=CC=CC=C2NC2=C1C=CN=C2C PSFDQSOCUJVVGF-UHFFFAOYSA-N 0.000 description 2
- 230000002706 hydrostatic effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000004079 Prolyl Hydroxylases Human genes 0.000 description 1
- 108010043005 Prolyl Hydroxylases Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 1
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- -1 lipid peroxides Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
组别 | 剂量(g/kg·bw) | 羟脯氨酸含量 |
空白组 | — | 0.98±0.13 |
模型组 | — | 0.61±0.07<sup>##</sup> |
对照组1 | 1.0 | 0.79±0.11* |
对照组2 | 1.0 | 0.66±0.10 |
对照组3 | 1.0 | 0.64±0.12 |
低剂量实验组 | 0.5 | 0.88±0.08** |
高剂量实验组 | 1.0 | 0.91±0.05** |
组别 | 剂量(g/kg·bw) | SOD(U/mgprot) | MDA(nmol/mgprot) |
空白组 | — | 132.44±4.13 | 10.27±1.34 |
模型组 | — | 82.61±9.07<sup>##</sup> | 13.55±1.16<sup>##</sup> |
对照组1 | 1.0 | 96.79±6.38* | 13.29±0.83 |
对照组2 | 1.0 | 84.34±9.88 | 13.43±0.62 |
对照组3 | 1.0 | 83.48±7.65 | 13.47±0.52 |
低剂量实验组 | 0.5 | 106.36±5.98** | 12.52±0.44** |
高剂量实验组 | 1.0 | 110.31±9.62** | 12.08±0.59** |
组别 | 剂量(g/kg·bw) | 羟脯氨酸含量 |
空白组 | — | 1.88±0.13 |
模型组 | — | 1.51±0.07<sup>##</sup> |
对照组1 | 1.0 | 1.59±0.06 |
对照组2 | 1.0 | 1.52±0.11 |
对照组3 | 1.0 | 1.53±0.26 |
低剂量实验组 | 0.5 | 1.68±0.08** |
高剂量实验组 | 1.0 | 1.73±0.05** |
项目 | 指标 |
感官 | 棕色粉末,当归提取物固有气味,无异味 |
阿魏酸,%≥ | 1.0 |
水分,%≤ | 10.0 |
灰分,%≤ | 10.0 |
菌落总数,CFU/g≤ | 1000 |
大肠菌群,MPN/100g≤ | 40 |
项目 | 指标 |
感官 | 棕色粉末,黄芪提取物固有气味,无异味 |
黄芪甲苷,%≥ | 10.0 |
水分,%≤ | 10.0 |
灰分,%≤ | 10.0 |
菌落总数,CFU/g≤ | 1000 |
大肠菌群,MPN/100g≤ | 40 |
项目 | 指标 |
感官 | 白色粉末,胶原蛋白固有气味,无异味 |
蛋白质,%≥ | 90.0 |
水分,%≤ | 10.0 |
灰分,%≤ | 10.0 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710351767.2A CN107198766B (zh) | 2017-05-18 | 2017-05-18 | 一种用于养颜的中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710351767.2A CN107198766B (zh) | 2017-05-18 | 2017-05-18 | 一种用于养颜的中药组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107198766A CN107198766A (zh) | 2017-09-26 |
CN107198766B true CN107198766B (zh) | 2020-09-22 |
Family
ID=59905742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710351767.2A Active CN107198766B (zh) | 2017-05-18 | 2017-05-18 | 一种用于养颜的中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107198766B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101099843A (zh) * | 2007-07-18 | 2008-01-09 | 广州中医药大学 | 一种延缓皮肤衰老的中药组合物 |
CN102349861A (zh) * | 2011-10-13 | 2012-02-15 | 四川大学 | 一种酚酸类改性胶原蛋白面膜及其制备方法 |
CN103099842A (zh) * | 2011-11-14 | 2013-05-15 | 甘肃创兴生物工程有限责任公司 | 有助于增加骨密度的软胶囊及其制备方法 |
CN105494858A (zh) * | 2015-12-17 | 2016-04-20 | 界首市奥源食品有限责任公司 | 一种美容抗衰瑞士糖 |
CN105535923A (zh) * | 2016-01-13 | 2016-05-04 | 安徽生物肽产业研究院有限公司 | 一种用于治疗肾病及心血管疾病的水蛭小肽有效部位组合物 |
-
2017
- 2017-05-18 CN CN201710351767.2A patent/CN107198766B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101099843A (zh) * | 2007-07-18 | 2008-01-09 | 广州中医药大学 | 一种延缓皮肤衰老的中药组合物 |
CN102349861A (zh) * | 2011-10-13 | 2012-02-15 | 四川大学 | 一种酚酸类改性胶原蛋白面膜及其制备方法 |
CN103099842A (zh) * | 2011-11-14 | 2013-05-15 | 甘肃创兴生物工程有限责任公司 | 有助于增加骨密度的软胶囊及其制备方法 |
CN105494858A (zh) * | 2015-12-17 | 2016-04-20 | 界首市奥源食品有限责任公司 | 一种美容抗衰瑞士糖 |
CN105535923A (zh) * | 2016-01-13 | 2016-05-04 | 安徽生物肽产业研究院有限公司 | 一种用于治疗肾病及心血管疾病的水蛭小肽有效部位组合物 |
Non-Patent Citations (1)
Title |
---|
退白汤中当归、黄芪、丹参、首乌、补骨脂的TLC法鉴别;盛国荣;《海峡药学》;20121231;第24卷(第1期);62-64 * |
Also Published As
Publication number | Publication date |
---|---|
CN107198766A (zh) | 2017-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104187679B (zh) | 一种雨生红球藻玛咖保健品及其制备方法 | |
US20120328721A1 (en) | Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects | |
CN106236644A (zh) | 一种水嫩润透精华液 | |
KR20100022137A (ko) | 녹용을 포함하는 발효 한방 생약 추출물을 함유한 탈모방지용 화장품 샴푸 제조방법 및 샴푸 | |
CN103211730A (zh) | 一种由天然中草药制成的美容精华液及其制备方法 | |
KR101002774B1 (ko) | 생약재를 주재로 한 환제 정력보강식품 및 그 제조방법 | |
KR101046438B1 (ko) | 피부 주름 개선 및 피부 수렴 작용을 갖는 혼합 식물추출물을 함유한 화장료 조성물 및 그 제조방법 | |
CN108771757A (zh) | 一种保健足贴组合物及保健足贴 | |
CN101104006A (zh) | 一种冬虫夏草菌提取浓缩液的制备方法及其应用 | |
CN104489172A (zh) | 一种提高免疫力的刺五加保健茶及其制备方法 | |
KR20150033797A (ko) | 아토피성 피부질환 예방 및 치료용 약학적 조성물 | |
CN108066384A (zh) | 一种具有增强免疫力功能的中药制剂及其制备方法 | |
CN107198766B (zh) | 一种用于养颜的中药组合物及其制备方法和应用 | |
CN113633719B (zh) | 一种抗氧化组合物及制备方法、应用 | |
KR102041867B1 (ko) | 오크라, 퀴노아, 석류, 들깨, 편백 추출 혼합물과 프로폴리스 및 합성펩타이드를 함유하는 피부화장료 조성물 | |
KR101911877B1 (ko) | 생약재 추출물을 유효성분으로 포함하는 관절염 개선용 건강기능식품 조성물 | |
CN110679939A (zh) | 一种具有美容、美白、润肤和祛斑功能的食品组合物 | |
CN104997885B (zh) | 一种具有美容作用的中药组合物 | |
CN114668809B (zh) | 一种用于改善整形美容副作用的药物 | |
KR101611966B1 (ko) | 녹용함유 한약추출물과 엠에스엠을 이용한 약학조성물 제조방법 | |
KR102217263B1 (ko) | 피부용 디톡스 조성물 | |
CN108543033B (zh) | 一种疏肝健脾美白祛斑的植物组合物及制备方法 | |
KR101027447B1 (ko) | 전복추출물을 함유하는 화장품 조성물 및 이의 제조방법 | |
CN102631487B (zh) | 提高免疫力、抗疲劳的中药组合物 | |
CN105617139A (zh) | 一种具有美白功效的中药组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a traditional Chinese medicine composition for nourishing beauty and a preparation method and application thereof Effective date of registration: 20220104 Granted publication date: 20200922 Pledgee: Zijin Branch of Nanjing Bank Co.,Ltd. Pledgor: NANJING ZHONGKE PHARMACEUTICAL Co.,Ltd.|ZHONGKE HEALTH INDUSTRY GROUP CO.,LTD. Registration number: Y2021980017453 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230206 Granted publication date: 20200922 Pledgee: Zijin Branch of Nanjing Bank Co.,Ltd. Pledgor: ZHONGKE HEALTH INDUSTRY GROUP CO.,LTD.|NANJING ZHONGKE PHARMACEUTICAL Co.,Ltd. Registration number: Y2021980017453 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |